Wockhardt Limited

FDA Regulatory Profile

Wockhardt Limited appears in FDA public data with 2 recalls, 0 510(k) clearances, 13 FDA inspections, and 2 compliance actions on record. Its most recent recall (D-0913-2018, Class III) was initiated on June 19, 2018.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
13
Compliance Actions
2

Recent Recalls

NumberClassProductDate
D-0913-2018Class IIIEnalapril Maleate Tablets USP; 2.5 mg NDC code 64679-923-03. 1000 Tablets HDPE container pack with NJune 19, 2018
D-0912-2018Class IIIEnalapril Maleate Tablets USP; 5 mg NDC code 64679-924-03. 1000 Tablets HDPE container pack with NonJune 19, 2018